1α-hydroxyvitamin D3, hypercalcemia, and growth suppression of 7,12-dimethylbenz[a]anthracene-induced rat mammary tumors

Breast Cancer Research and Treatment

Volumn 22, Issue 2, 1992, Pages 133-140

  Iino, Yuichi ^a   Yoshida, Masao ^a   Sugamata, Noritaka ^a   Maemura, Michio ^a   Ohwada, Susumu ^a   Yokoe, Takao ^a   Ishikita, Toshikazu ^a   Horiuchi, Ryuya ^b   Morishita, Yasuo ^a  

^a GUNMA UNIVERSITY   (Japan)

^b GUNMA UNIVERSITY   (Japan)

Author keywords

1 hydroxyvitamin D3; antitumor effects; DMBA induced rat mammary tumor; estrogen receptor; hypercalcemia; medroxyprogesterone acetate

Indexed keywords

ALFACALCIDOL; DIMETHYLBENZ[A]ANTHRACENE; ESTROGEN RECEPTOR; FLUOROURACIL;

ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; BREAST TUMOR; CALCIUM BLOOD LEVEL; CANCER COMBINATION CHEMOTHERAPY; CANCER INHIBITION; CONTROLLED STUDY; DOSE RESPONSE; DRUG MIXTURE; FEMALE; HYPERCALCEMIA; INTRAMUSCULAR DRUG ADMINISTRATION; INTRAPERITONEAL DRUG ADMINISTRATION; NONHUMAN; RAT; WEIGHT REDUCTION;

9,10-DIMETHYL-1,2-BENZANTHRACENE; ANIMAL; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CELL DIVISION; FEMALE; FLUOROURACIL; HYDROXYCHOLECALCIFEROLS; HYPERCALCEMIA; MAMMARY NEOPLASMS, EXPERIMENTAL; MEDROXYPROGESTERONE 17-ACETATE; RATS; RATS, SPRAGUE-DAWLEY; WEIGHT LOSS;

EID: 0026774589     PISSN: 01676806     EISSN: 15737217     Source Type: Journal    
DOI: 10.1007/BF01833343     Document Type: Article

References (33)

1. Differentiation of mouse myeloid leukemia cells induced by 1α,25-dihydroxyvitamin D3
2. 1α,25-dihydroxycycholecalciferol and human myeloid leukaemia cell line (HL-60)
3. Induction of differentiation of the human histiocytic lymphoma cell line U-937 by 1α,25-dihydroxycholecalciferol
4. Modulation of cell growth, differentiation, and production of interleukin-3 by 1α,25-dihydroxyvitamin D3 in the murine myelocytic leukemia
5. Successful treatment with alfacalcidol for a patient with hypoplastic leukemia
6. Treatment of myelodysplastic syndrome and acute myelogenous leukemia with vitamin D3 [1α(OH)D3]
7. Successful treatment of a patient with acute myeloid leukemia with 1α(OH)D3
8. Normal and malignant breast tissue is a target organ for 1,25-(OH)2 vitamin D3
9. Specific cytosol binding proteins for 25(OH)D3 and 1,25(OH)2D3 in human breast cancers
10. Frequency of 1α,25-dihydroxyvitamin D3 receptor in human breast cancer
11. Sucrose density gradient analysis of 1α,25-dihydroxyvitamin D3 binding in human breast tumors
12. Measurement of 1,25-dihydroxyvitamin D3 receptors in breast cancer and their relationship to biochemical and clinical indices
13. Systematic search for 1α,25-dihydroxyvitamin D3 receptors in human breast carcinomas
14. Immunocytochemical detection of 1,25-dihydroxyvitamin D3 receptor in breast cancer
15. Possible role for vitamin D in controlling breast cancer cell proliferation
16. Inhibition of human cancer cell growth by 1,25-dihydroxyvitamin D3 metabolites
17. 1,25-dihydroxyvitamin D3 inhibitory effect on the growth of two human breast cancer cell lines (MCF-7, BT-20)
18. Calcium antagonizes 1,25-dihydroxyvitamin D3 inhibition of breast cancer cell proliferation
19. Estrogen receptor assay in human breast cancer tissue using 16α-125I-estradiol-17β
20. Effects of chemo-endocrine therapy on advanced human breast cancer and 7,12-dimethylbenz[a]anthracene induced mammary tumor
21. 1,25-dihydroxyvitamin D3 and malignant melanoma: the presence of receptor and inhibition of cell growth in culture
22. 1,25-dihydroxyvitamin D3 stimulates the alkaline phosphatase activity of osteoblast-like cells
23. Antitumor effect of 1α-hydroxyvitamin D3
24. Antitumor effect of vitamin D3 on Dunn osteosarcoma
25. Suppression of in vivo growth of human cancer solid xenografts by 1α,25-dihydroxyvitamin D3
26. 1α,25-dihydroxyvitamin D3 and 1α-hydroxyvitamin D3 prolong survival time of mice inoculated with myeoloid leukemia cells
27. Synthetic analogues of vitamin D3 with an oxygen atom in the side chain skeleton
28. Effects of a novel vitamin D analogue MC 903 on cell proliferation and differentiation in vitro and on calcium metabolism in vitro
29. Novel vitamin D analogues that modulate leukemic cell growth and differentiation with little effect on either intestinal calcium absorption or bone calcium mobilization
30. Control of proliferating potential of myeloid leukemia cells during long-term treatment with vitamin D3 analogues and other differentiation inducers in combination with antileukemic drugs: in vitro and in vivo studies
31. Oral high-dose medroxy-progesterone acetate (MPA) in the treatment of advanced and recurrent breast cancer: a dose-response evaluation
32. Therapeutic effects of medroxyprogesterone acetate in recurrent or advanced breast cancer
33. Inhibitory effects of oral administration of medroxyprogesterone acetate and mepitiostane on 7,12-dimethylbenz[a]anthracene-induced rat mammary cancer